Abstract
The purpose of this article is to report the development of Fuchs’ heterochromic cyclitis (FHC) secondary to toxoplasmosis chorioretinitis. The design is based on observational case series report. We report in this article six cases of typical FHC developing secondary to ocular toxoplasmosis. Intraocular immunoglobulin G production against Toxoplasma gondii was determined in the aqueous humor of five patients by calculation of the Goldmann–Witmer coefficient (GWC). The clinical examination revealed typical FHC with no active chorioretinal scar. We report on five women and one man (aged 33–64 years old; median 44.6 years) who developed FHC over a period of time ranging from 2–13 years. A positive GWC (>3) was found in four patients; of the two remaining patients one was negative and the other did not have anterior chamber paracentesis. Four patients were treated for an active ocular toxoplasmic lesion before the development of FHC with pyrimethamine, sulfadiazine and corticosteroids. Two patients had negative anti-toxoplasmic therapy for FHC (one with trimethoprim-sulfamethoxazole for 3 weeks and the other with pyrimethamine, sulfadiazine and corticosteroids for 8 weeks). One never had any treatment. All the patients had mild anterior chamber reaction with no synechia, diffuse and characteristic white stellate keratic precipitates and vitritis; five patients had posterior subcapsular cataract and heterochromia and three had elevated intraocular pressure. The findings help us to conclude that FHC can develop over a period of time after ocular toxoplasmosis. This could be a main association to search for when a Fuchs’ uveitis is found with a chorioretinal scar. Ocular inflammation does not mean reactivation of ocular toxoplasmosis. FHC could be a secondary immune reaction with a past antigenic stimulation to a previous infection, i.e., toxoplasmosis, etc.
References
Bonfioli AA, Curi AL, Orefice F (2005) Fuchs’ heterochromic cyclitis. Semin Ophthalmol 20(3):143–146
Jones NP (1991) Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye 5(Pt 6):649–661
Jones NP (1991) Glaucoma in Fuchs’ heterochromic uveitis: aetiology, management and outcome. Eye 5(Pt 6):662–667
Van Gelder RN (2008) Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis. Am J Ophthalmol 145(5):769–771
Makley TA Jr (1956) Heterochromic cyclitis in identical twins. Am J Ophthalmol 41(5):768–772
Spriewald BM, Lefter C, Huber I et al (2007) A suggestive association of Fuch’s heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism. Ophthalmic Res 39(2):116–120
Munoz G, Lopez-Corell MP, Taboada JF et al (1994) Fuch’s heterochromic cyclitis and HLA histocompatibility antigens. Int Ophthalmol 18(3):127–130
de Groot-Mijnes JD, de Visser L, Rothova A et al (2006) Rubella virus is associated with Fuch’s heterochromic iridocyclitis. Am J Ophthalmol 141(1):212–214
Quentin CD, Reiber H (2004) Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138(1):46–54
de Visser L, Braakenburg A, Rothova A, de Boer JH (2008) Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol 146(2):292–297
Teyssot N, Cassoux N, Lehoang P, Bodaghi B (2005) Fuchs heterochromic cyclitis and ocular toxocariasis. Am J Ophthalmol 139(5):915–916
Barequet IS, Li Q, Wang Y et al (2000) Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol 129(5):672–673
Chee SP, Jap A (2008) Presumed Fuch’s heterochromic iridocyclitis and Posner–Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol 146(6):883–889 e1
Ganesh SK, Sharma S, Narayana KM, Biswas J (2004) Fuchs’ heterochromic iridocyclitis following bilateral ocular toxoplasmosis. Ocul Immunol Inflamm 12(1):75–77
Parrat E, Brousse D, Cousin P et al (1999) Fuchs’ uveitic syndrome in a patient with ocular toxoplasmosis. J Fr Ophtalmol 22(10):1067–1071
Toledo de Abreu M, Belfort R Jr, Hirata PS (1982) Fuchs’ heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol 93(6):739–744
Schwab IR (1991) The epidemiologic association of Fuchs’ heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 111(3):356–362
Gilbert RE, Stanford MR, Jackson H et al (1995) Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ 310(6986):1037–1040
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509–516
la Hey E, Baarsma GS, Rothova A et al (1988) High incidence of corneal epithelium antibodies in Fuch’s heterochromic cyclitis. Br J Ophthalmol 72(12):921–925
La Hey E, Broersma L, van der Gaag R et al (1993) Does autoimmunity to S-antigen play a role in Fuchs’ heterochromic cyclitis? Br J Ophthalmol 77(7):436–439
Muhaya M, Calder VL, Towler HM et al (1999) Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol 116(3):410–414
Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85(1):9–18 quiz 21
Labalette P, Caillau D, Grutzmacher C et al (2002) Highly focused clonal composition of CD8(+) CD28(neg) T cells in aqueous humor of Fuchs heterochromic cyclitis. Exp Eye Res 75(3):317–325
Davidson, MG, Lappin MR et al (1993) A feline model of ocular toxoplasmosis. Invest Ophthalmol Vis Sci 34(13):3653–3660
La Hey E, Baarsma GS (1993) Contralateral active ocular toxoplasmosis in Fuchs’ heterochromic cyclitis. Br J Ophthalmol 77(7):455–456
La Hey E, de Jong PT, Kijlstra A (1994) Fuchs’ heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol 78(4):307–312
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jad, A., Céline, T., Bahram, B. et al. Fuchs’ heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?. Int Ophthalmol 33, 189–194 (2013). https://doi.org/10.1007/s10792-012-9649-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-012-9649-7